Published ahead of print on February 10, 2005, doi:10.1165/rcmb.2004-0274OC
Am. J. Respir. Cell Mol. Biol., Volume 32, Number 5, May 2005, 411-419
A more recent version of this article appeared on May 1, 2005
Submitted on August 26, 2004
Revised on February 10, 2005
Pseudomonas aeruginosa elastase disables PAR2 in respiratory epithelial cells
Sophie Dulon1, Dominique Leduc1, Graeme S Cottrell2, Jacques D'Alayer3, Kristina K Hansen4, Nigel W Bunnett2, Morley D Hollenberg4, Dominique Pidard1, and Michel Chignard1*
1 Defense innee et inflammation, Institut Pasteur, Paris, France,
2 Departments of Surgery and Physiology, University of California, San Francisco, San Francisco, California, USA,
3 Plateforme d'Analyse et de Microsequencage des Proteines, Institut Pasteur, Paris, France,
4 Department of Pharmacology and Therapeutics, University of Calgary, Calgary, Alberta, Canada
* To whom correspondence should be addressed. E-mail: chignard{at}pasteur.fr.
Pseudomonas aeruginosa, a major lung pathogen in cystic fibrosis (CF) patients, secretes an elastolytic metalloproteinase (EPa) contributing to bacterial pathogenicity. Proteinase-activated receptor 2 (PAR2), implicated in the pulmonary innate defense, is activated by the cleavage of its extracellular N-terminal domain, unmasking a new N-terminal sequence starting with SLIGKV, which binds intramolecularly and activates PAR2. We show that EPa cleaves the N-terminal domain of PAR2 from the cell surface without triggering receptor endocytosis as trypsin does. As evaluated by measurements of cytosolic calcium as well as PGE2 and IL-8 production, this cleavage does not activate PAR2, but rather disarms the receptor for subsequent activation by trypsin, but not by the synthetic receptor-activating peptide, SLIGKV-NH2. Proteolysis by EPa of synthetic peptides representing the N-terminal cleavage/activation sequences of either human or rat PAR2 indicates that cleavages resulting from EPa activity would not produce receptor-activating tethered ligands, but would disarm PAR2 in regard to any further activating proteolysis by activating proteinases. Our data indicate that a pathogen-derived proteinase like EPa can potentially silence the function of PAR2 in the respiratory tract, thereby altering the host innate defense mechanisms and respiratory functions, thus contributing to pathogenesis in the setting of a disease like CF.
This article has been cited by other articles:

|
 |

|
 |
 
P. Rallabhandi, Q. M. Nhu, V. Y. Toshchakov, W. Piao, A. E. Medvedev, M. D. Hollenberg, A. Fasano, and S. N. Vogel
Analysis of Proteinase-activated Receptor 2 and TLR4 Signal Transduction: A NOVEL PARADIGM FOR RECEPTOR COOPERATIVITY
J. Biol. Chem.,
September 5, 2008;
283(36):
24314 - 24325.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. J. Ramsay, Y. Dong, M. L. Hunt, M. Linn, H. Samaratunga, J. A. Clements, and J. D. Hooper
Kallikrein-related Peptidase 4 (KLK4) Initiates Intracellular Signaling via Protease-activated Receptors (PARs): KLK4 AND PAR-2 ARE CO-EXPRESSED DURING PROSTATE CANCER PROGRESSION
J. Biol. Chem.,
May 2, 2008;
283(18):
12293 - 12304.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. J. Moraes, R. Martin, J. D. Plumb, E. Vachon, C. M. Cameron, A. Danesh, D. J. Kelvin, W. Ruf, and G. P. Downey
Role of PAR2 in murine pulmonary pseudomonal infection
Am J Physiol Lung Cell Mol Physiol,
February 1, 2008;
294(2):
L368 - L377.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Leduc, N. Beaufort, S. de Bentzmann, J.-C. Rousselle, A. Namane, M. Chignard, and D. Pidard
The Pseudomonas aeruginosa LasB Metalloproteinase Regulates the Human Urokinase-Type Plasminogen Activator Receptor through Domain-Specific Endoproteolysis
Infect. Immun.,
August 1, 2007;
75(8):
3848 - 3858.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Kida, H. Inoue, T. Shimizu, and K. Kuwano
Serratia marcescens Serralysin Induces Inflammatory Responses through Protease-Activated Receptor 2
Infect. Immun.,
January 1, 2007;
75(1):
164 - 174.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Oikonomopoulou, K. K. Hansen, M. Saifeddine, I. Tea, M. Blaber, S. I. Blaber, I. Scarisbrick, P. Andrade-Gordon, G. S. Cottrell, N. W. Bunnett, et al.
Proteinase-activated Receptors, Targets for Kallikrein Signaling
J. Biol. Chem.,
October 27, 2006;
281(43):
32095 - 32112.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Chignard and D. Pidard
Neutrophil and Pathogen Proteinases versus Proteinase-Activated Receptor-2 Lung Epithelial Cells: More Terminators than Activators.
Am. J. Respir. Cell Mol. Biol.,
April 1, 2006;
34(4):
394 - 398.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Holzhausen, L. C. Spolidorio, R. P. Ellen, M.-C. Jobin, M. Steinhoff, P. Andrade-Gordon, and N. Vergnolle
Protease-Activated Receptor-2 Activation: A Major Role in the Pathogenesis of Porphyromonas gingivalis Infection
Am. J. Pathol.,
April 1, 2006;
168(4):
1189 - 1199.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Suzuki, T. J. Moraes, E. Vachon, H. H. Ginzberg, T.-T. Huang, M. A. Matthay, M. D. Hollenberg, J. Marshall, C. A. G. McCulloch, M. T. H. Abreu, et al.
Proteinase-Activated Receptor-1 Mediates Elastase-Induced Apoptosis of Human Lung Epithelial Cells
Am. J. Respir. Cell Mol. Biol.,
September 1, 2005;
33(3):
231 - 247.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2005 American Thoracic Society.
|
|
|